Autism is believed to suffer from 1 in 68 children with varying levels of conditions. Only a few drugs are currently approved for the treatment of autism, including Risperidone and Aripiprazole. Both are anti-psychotic drugs which are basically just sedatives. Parents face a big risk by giving their children pharmaceutical products like antipsychotic drugs, even though the product seems to work.
Treatment with sedatives like this also requires a high cost and causes dangerous side effects that can actually make some symptoms of autism worse. Even in some cases, these drugs refer to the cause of weight gain, diabetes to heart disease. Anti-psychotic drugs can also cause extreme lethargy and sedation.
2016 is an important year in the history of Medical Marijuana research. In September, Israel became the first country in the world to be given permission to treat autistic children in a clinical trial with marijuana in a doctor’s approved monitoring program. Noa Shulman is one of 120 children and adolescents who participated in this study. The youngest is five years old and the oldest is 29. The form of autism ranges from mild to severe.
During this study, Noa received her daily drug dosage in the form of marijuana extract oil mixed with her food. The Medical Cannabis extract given to Noa is rich in cannabidiol (CBD), a unique compound that is only found in cannabis plants and does not provide a psychoactive effect. Patients in this study were given marijuana and placebo was given to other patients. Symptoms of autism in patients, such as aggression and anger, were greatly reduced with marijuana use compared to placebo. During the study, Noa often looked calmer and not irritable.
“When my daughter uses antipsychotic drugs, she is like a zombie. He will only sit there with his mouth wide open, not moving. “Said Yael, mother Noa.
“I really got to the point where I no longer had the strength – physically or emotionally,” he continued. Currently, it is part of the research that is able to give new hope for Yael regarding the condition of his child, Noa.
Research on autism is one of more than 110 studies conducted in Israel, which has developed a reputation as a country that pioneered medical marijuana research. The main psychoactive in marijuana, THC, was first isolated by Israeli scientists in the late 1960s.
This clinical research is expected to add some quality scientific evidence that can claim that marijuana is a breakthrough in the world of treatment for autism. But it seems that parents and autism patients all over the world must be patient waiting for this study to be completed in 2018 to get the results of the study entirely and find out which marijuana extract is the most effective level of concentration for autism sufferers.
Previously there was a lot of anecdotal evidence that medical marijuana treatment was very helpful for children and adults with severe forms of autism. In the United States, advocacy groups are campaigning for autism to access treatment in US states where medical marijuana is legalized. Some states, like Pennsylvania, are now starting to allow autism patients to access medical marijuana to help overcome symptoms that harm themselves and their environment. Unfortunately, in most other countries around the world, this has not been realized because marijuana is still classified in the list of dangerous narcotics.